Company news
Immupharma Plc (LSE:IMM) news
Every Immupharma Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Bioanalytical CRO partner for Kapiglucagon
August 10, 2026
Thermo Fisher CDMO selected for Kapiglucagon pro
July 22, 2026
2026 RESULT OF ANNUAL GENERAL MEETING
June 25, 2026
University of Murcia research relating to P140
June 24, 2026
Incanthera plc – Corporate Update & Board Changes
June 4, 2026
ImmuPharma : FINAL RESULTS for the twelve months ended 31 December 2025
May 27, 2026
IMM initiatesIND-Enabling Program for Kapiglucagon
May 5, 2026
Holding(s) in Company
April 10, 2026
Chairman’s Open Letter to Shareholders
April 9, 2026
Result of General Meeting and TVR
April 7, 2026
P140 Program Update
March 27, 2026
Result of WRAP Retail Offer and TVR
March 23, 2026
Publication of Circular
March 19, 2026
‘Investor Meet Company’ presentation on 20 March
March 18, 2026
WRAP Retail Offer for up to £1.5 million
March 17, 2026
Attending JPMorgan Conference & Biotech Showcase
January 6, 2026
Corporate Update
November 24, 2025
IMMUPHARMA ATTENDING BIO-EUROPE
October 27, 2025
Launch of Website; Corporate Update
October 23, 2025
Appointment of Independent Non-Executive Director
October 13, 2025
Exercise of Warrants
September 17, 2025
Appointments of CSO and Head of R&D
September 1, 2025
Interim Results
August 6, 2025
Result of AGM
June 12, 2025
Notice of AGM
May 20, 2025
Final Results
May 19, 2025
Warrant Extension, Debt Conversion & Equity Issue
April 1, 2025
IMM attending Bio-Europe Spring 17-19 March,Milan
March 14, 2025
ImmuPharma proves unique Mechanism of Action-P140
March 13, 2025
£2.91m fundraising; related party transactions
February 13, 2025
Response to Share Price Movement
January 28, 2025
Breakthrough Findings into Autoimmune Diseases
January 9, 2025
IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE
January 8, 2025
Change of Auditor
December 23, 2024
Appointment of Company Secretary
December 4, 2024
Extension of Warrants in Incanthera to 31 Mar 2025
September 9, 2024
ImmuPharma : 2024 Result of Annual General Meeting – all resolutions passed
July 1, 2024
Notice of AGM & Annual Report & Accounts
June 5, 2024
Realisation-c£1.5m on sale of shares in Incanthera
June 3, 2024
IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
April 24, 2024
Grant of Share Options
April 19, 2024
New intellectual property strategy initiated
April 2, 2024
Incanthera provides Comm'l Update/Revenue F'casts
March 25, 2024
IMMUPHARMA AT BIO-EUROPE SPRING 2024
March 14, 2024
Financial, Business and Portfolio Develop't Update
March 6, 2024
Simbec-Orion appointed as CRO
December 19, 2023
Incanthera - Comm'l Skincare Deal/£1M Fundraise
December 18, 2023
Result of Retail Offer and Director Shareholding
September 7, 2023
WRAP Retail Offer for up to £0.5m
August 31, 2023
Extension of warrants in Incanthera plc
August 21, 2023